On August 10, 2016, the National Institute on Drug Abuse (NIDA) approved the Scottsdale Research Institute’s official request to order 6.3kg of marijuana to be used by the Phoenix, Ariz., study site in our upcoming study of medical marijuana for posttraumatic stress disorder (PTSD) in U.S. veterans. Multiple marijuana strains were requested, featuring varying levels of THC and CBD per strain, including high THC, high CBD, balanced THC/CBD, and placebo. On July 22, an independent Institutional Review Board (IRB) approved the fifth protocol amendment for the Scottsdale Research Institute’s portion of the study, which included changes to clarify several study procedures and adjust study measures. On August 1, the amendment was submitted to the FDA, and to the Drug Enforcement Administration (DEA) on August 2. We will begin screening study participants after NIDA provides a scheduled delivery date for the marijuana. Learn more…
